Amphista Therapeutics operates as a biopharmaceutical company.
Amphista Therapeutics's investors include Dementia Discovery Fund, Forbion Capital Partners, European Investment Fund, Gilde Healthcare, Eli Lilly & Company Foundation.
Amphista Therapeutics is headquartered in Cambridge, United Kingdom.
Amphista Therapeutics operates as a biopharmaceutical company.
Amphista Therapeutics is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Amphista Therapeutics — Funding & Investors." VCBacked, December 13, 2022, https://www.vcbacked.co/company/amphista-therapeutics. Accessed August 14, 2026.
VCBacked. (2022). Amphista Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/amphista-therapeutics
{{cite web |title=Amphista Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/amphista-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated